Latest Production News

Black Canyon Limited’s Phase 2 drilling at the Wandanya Project confirms extensive high-grade manganese and iron mineralisation, revealing significant scale and promising exploration upside.

Aquirian Limited has secured $5 million in fresh capital to upgrade its Wubin emulsion facility and accelerate commercialization of its innovative Collar Keeper® technology, alongside a new $1.5 million tolling contract.

Finder Energy has opened a new office in Dili to support its KTJ oil fields project, signalling a strategic push to embed local operations and partnerships in Timor-Leste.

Sports Entertainment Group upgrades its FY25 EBITDA forecast to $9m-$10m, driven by strategic divestments and new media initiatives, setting the stage for continued growth in FY26.

Argosy Minerals has executed a spot sales contract for 60 tonnes of high-purity lithium carbonate from its Rincon project, marking a significant step in its lithium market engagement.

Papyrus Australia has successfully expanded its banana fibre technology to produce boards and flat paper products, while advancing a promising joint venture in Vietnam for high-volume production.

Capricorn Metals has fully repaid its remaining $50 million corporate debt ahead of schedule, positioning itself as debt and gold hedging free with strong cash reserves to back growth projects.

Aerometrex has renewed and extended its multi-million dollar agreement with Landchecker, significantly increasing its annual recurring revenue through the MetroMap platform.

Mineral Commodities Ltd has extended the maturity date of its A$2.4 million convertible loan facility, tying repayment timing to the potential sale of its Skaland asset. This move provides the company with greater financial flexibility as it navigates strategic asset sales.

Andromeda Metals has launched a $5 million capital raising via a Placement, accompanied by Placement and Broker Options, to advance its flagship Great White Project and High Purity Alumina development.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.